Pathophysiology and diagnosis of dyspnea in patients with advanced cancer
- PMID: 20151345
- DOI: 10.1007/s10354-009-0725-1
Pathophysiology and diagnosis of dyspnea in patients with advanced cancer
Abstract
The reported prevalence of dyspnea in patients with various cancers ranges from 19% to 64%. For optimal clinical management of dyspnea in cancer patients, accurate diagnosis of the underlying cause and thorough understanding of the pathomechanisms of dyspnea seems mandatory. The clinical approach to a patient with advanced cancer and dyspnea should include adequate history taking, physical examination, and selected diagnostic investigations. These should be performed immediately to enable quick treatment decisions. In addition, self assessment of the intensity of dyspnea by the patient may help to assess patient's needs as soon as possible.
Similar articles
-
[Palliation of dyspnea in malignant disease].Ugeskr Laeger. 1999 Jan 18;161(3):244-8. Ugeskr Laeger. 1999. PMID: 10025221 Review. Danish.
-
Dyspnea: the continuing challenge of palliative management.Curr Opin Oncol. 2002 Jul;14(4):394-8. doi: 10.1097/00001622-200207000-00004. Curr Opin Oncol. 2002. PMID: 12130922 Review.
-
Evaluation of diagnostic and treatment approaches to acute dyspnea in a palliative care setting among medical doctors with different educational levels.Support Care Cancer. 2022 Jul;30(7):5759-5768. doi: 10.1007/s00520-022-06996-6. Epub 2022 Mar 25. Support Care Cancer. 2022. PMID: 35338391 Free PMC article.
-
Dyspnoea in advanced malignancies: a palliative care approach.Ann Acad Med Singap. 1994 Mar;23(2):183-5. Ann Acad Med Singap. 1994. PMID: 7521608 Review.
-
Management of dyspnea.J Support Oncol. 2003 May-Jun;1(1):23-32; discussion 32-4. doi: 10.1007/978-1-59745-291-5_1. J Support Oncol. 2003. PMID: 15352640 Review.
Cited by
-
Systematic review and meta-analysis of the efficacy of benzodiazepines for dyspnea in patients with cancer.Jpn J Clin Oncol. 2023 Mar 30;53(4):327-334. doi: 10.1093/jjco/hyac206. Jpn J Clin Oncol. 2023. PMID: 36636762 Free PMC article.
-
Non-invasive neuromodulation for alleviating dyspnoea: protocol for a feasibility sham-controlled randomised trial.BMJ Open. 2025 Jul 22;15(7):e103891. doi: 10.1136/bmjopen-2025-103891. BMJ Open. 2025. PMID: 40701604 Free PMC article.
-
Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer.Qual Life Res. 2016 Jan;25(1):165-74. doi: 10.1007/s11136-015-1063-y. Epub 2015 Jul 9. Qual Life Res. 2016. PMID: 26156405
-
Symptomatic treatment of dyspnea in advanced cancer patients : A narrative review of the current literature.Wien Med Wochenschr. 2018 Oct;168(13-14):333-343. doi: 10.1007/s10354-017-0600-4. Epub 2017 Sep 18. Wien Med Wochenschr. 2018. PMID: 28921042 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical